NDC 72162-1262-01 - Nitrofurantoin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1262
- Requested NDC
- 72162-1262-01
- Package NDCs from labels
- 72162-1262-0, 72162-1262-1, 72162-1262-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nitrofurantoin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-08-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1262-0 | Nitrofurantoin | 1000 in 1 BOTTLE | CAPSULE | 1000 | 101 | |
| 72162-1262-1 | Nitrofurantoin | 100 in 1 BOTTLE | CAPSULE | 100 | 101 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1262 | NITROFURANTOIN CAPSULE [BRYANT RANCH PREPACK] | 101 | Current NDC, 2 package rows | 20240829_56e07ad3-7224-4aaf-9a68-0d48d4abfec8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1262-0 | EA - Each | 72162-1262 | ac967345-32c6-45b5-805a-3b15f17b0d07 | 1 | 2024-10-04 |
| 72162-1262-1 | EA - Each | 72162-1262 | bbb93c3e-856d-42f2-b9a5-c0d70ceec7de | 1 | 2023-10-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nitrofurantoin | NITROFURANTOIN | Somerset Therapeutics, LLC | dd99ba40-edff-47c3-9ee4-7e5b7774e5b5 | 2026-01-22 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Preferred Pharmaceuticals Inc. | 11e8f91c-5712-4267-9956-e619d081d1f4 | 2026-01-16 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | A-S Medication Solutions | 2a772eb3-4fb3-4d92-b9f4-469dd2216361 | 2026-01-06 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | PD-Rx Pharmaceuticals, Inc. | 7767697f-4dd0-477d-b5cc-e1ed5689f097 | 2026-01-05 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | PD-Rx Pharmaceuticals, Inc. | 643cdcff-8599-4326-b3ca-d9fd270e0fc2 | 2026-01-05 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Northwind Health Company, LLC | 04b4189e-9b21-78ed-e063-6394a90ab8e0 | 2026-01-01 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| nitrofurantoin macrocrystals | NITROFURANTOIN MACROCRYSTALS | Northwind Health Company, LLC | 075fe819-fc4f-2dce-e063-6294a90ad823 | 2025-12-26 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin Macrocrystals | NITROFURANTOIN MACROCRYSTALS | Redpharm Drug | 32520c80-0ce5-ea4b-e063-6294a90a37ba | 2025-12-18 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | QPharma, Inc. | fbc05ccb-782b-55f6-e053-6394a90a7fd6 | 2025-12-16 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | NuCare Pharmaceuticals,Inc. | 155c8d68-576e-f85c-e063-6294a90ada4b | 2025-12-10 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Redpharm Drug | 3dd034a6-8810-93f5-e063-6394a90a36c2 | 2025-12-02 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | QPharma, Inc. | 055477be-e42c-fe8b-e063-6394a90a0449 | 2025-12-01 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin | NITROFURANTOIN | Rising Pharma Holdings, Inc. | 89095f4d-e142-465e-b378-da24f6eeaf2b | 2025-11-11 | Warnings, Adverse reactions | 927AH8112L |
| nitrofurantoin macrocrystals | NITROFURANTOIN MACROCRYSTALS | VERITYRX, LLC | 42a1c744-93dc-31cc-e063-6294a90ab912 | 2025-11-02 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin | NITROFURANTOIN | Bryant Ranch Prepack | 1c5db054-58af-4932-8fad-c3883b13f987 | 2025-10-22 | Warnings, Adverse reactions | ANDA208516 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin Monohydrate/ Macrocrystalline | NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE | Alvogen Inc. | 1a86deef-0887-43b1-bb96-dbc222b15931 | 2025-10-16 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Macrobid | NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE | Almatica Pharma LLC | 8f270a9f-12a1-44d4-bc7e-873613555801 | 2025-10-14 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN | NITROFURANTOIN | Proficient Rx LP | 0819be0b-03e9-426e-a4b9-624c32958f94 | 2025-09-01 | Warnings, Adverse reactions | 927AH8112L |
| NITROFURANTOIN | NITROFURANTOIN | Camber Pharmaceuticals, Inc. | 4e06b31e-cc49-4526-beb6-e77021823aa9 | 2025-08-13 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | A-S Medication Solutions | b644426c-c8ba-4fe0-80c7-d9b2dde37395 | 2025-08-13 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.